<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00820274</url>
  </required_header>
  <id_info>
    <org_study_id>I07011</org_study_id>
    <nct_id>NCT00820274</nct_id>
  </id_info>
  <brief_title>Evaluation of the Cryopreserved Amniotic Membranes in the Care of Resistant Vascular Ulcers</brief_title>
  <acronym>MAUV</acronym>
  <official_title>Evaluation of the Cryopreserved Amniotic Membranes in the Care of Resistant Vascular Ulcers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Limoges</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Etablissement Français du Sang</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Limoges</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate tolerance and efficiency of cryopreserved amniotic membranes in local treatment
      of resistant vascular ulcers.

      To evaluate complete cicatrisation, efficiency on pain, prevention of infection, improvement
      of quality of life.

      To evaluate rate of amputations and recurrence at one year after complete cicatrisation
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Treatment of patients suffering from vascular ulcers or amputation's wound from at least 6
      months after or without possibility for surgical treatment. A cryopreserved amniotic
      membrane, obtained after caesarean from consenting women without any disease, is applied on
      the ulcer after serological checking and changed once a week.

      Main criterias:

      Tolerance will be evaluated on clinical criterias. Efficiency will be evaluated by measuring
      reduction of ulcer's area (reduction of at least 50 % at 6 months).

      Secondary criterias:

      Reduction of pain will be evaluated by analogic visual scale and evaluation of analgesic
      consumption.

      Evaluation of infections, amputations, complete healing, improvement of quality of life by
      SF36 questionnaire and recurrence at one year for patients with complete healing.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    clinical trial have encountered difficulties enrolling a sufficient number of patients
  </why_stopped>
  <start_date>January 2009</start_date>
  <completion_date type="Anticipated">June 2016</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Measure of the diameter of the ulcer</measure>
    <time_frame>Every week</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Resistant Vascular Ulcers</condition>
  <arm_group>
    <arm_group_label>amniotic membranes</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>amniotic membranes</intervention_name>
    <description>The amniotic membrane is taken with a sterile crowbar then applied side foetal face against the ulcer and displayed in a homogeneous way</description>
    <arm_group_label>amniotic membranes</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Obtained informed consent

          -  Leg or foot arterial or mixed ulcer older than at least 3 months

        Exclusion Criteria:

          -  No obtained informed consent

          -  Possibility for surgical treatment (revascularisation)

          -  Age less than 18

          -  Pregnancy

          -  Indication for major amputation (below /above the knee)

          -  Venous ulcer

          -  Ulcer with infection and / or necrosis

          -  Mycotic ulcer
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Francis Pesteil, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Limoges</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Service de Médecine Interne et Pathologie Vasculaire</name>
      <address>
        <city>Bordeaux</city>
        <zip>33075</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de Chirurgie Vasculaire et Viscérale</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de Chirurgie Thoracique, cardiovasculaire et angiologie</name>
      <address>
        <city>Limoges</city>
        <zip>87000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 9, 2009</study_first_submitted>
  <study_first_submitted_qc>January 9, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 12, 2009</study_first_posted>
  <last_update_submitted>August 31, 2015</last_update_submitted>
  <last_update_submitted_qc>August 31, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 1, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ulcer</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

